25
Jan
“If you think research is expensive, try disease.” — Mary Lasker
In 2013 the budger for research and innovation in the EU was 10.84M (source: European Commision) Meanwhile, only in Spain in 2013 the Healthcare expenditure was 92,7M (source: Eurostat)
09
Jan
Leishmaniasis is on the list of 5 little-known diseases to watch out for in 2017
According to Derek Gatherer, lecturer at Lancaster University, leishmaniasis is among the diseases that are likely to emerge in 2017. This parasitic infection is one of those investigated by DIOMUNE and is best known in Spain for affecting dogs despite the fact that annually in Spain there are about 110 cases in humans. However, in... Read More
20
Dec
R&D in biotechnology is profitable despite the lack of budget
According to the ASEBIO report of 2015, R&D represents 10% of GDP in Spain, exceeding 100,000 million euros per year and reaching the level of tourism contributions. All despite the fact that, according to a COSCE report, in order to reach the 2009 budget level by 2026, a... Read More
07
Dec
Antimicrobial resistance to cause 10 million deaths by 2050
The indiscriminate use of antibiotics has increased exponentially and thus the ability of microbes to become resistant to such antibiotics. As a consequence, antibiotics become increasingly ineffective and ultimately completely useless for the treatment of infectious diseases. The problem is even greater if we consider that in some antimicrobial categories there are few or no... Read More
18
Nov
Age of First Stroke Is decreasing and rates are increasing in people under 55
An epidemiological study conducted at Michigan University shows a decrease of about 2 years in the average age of people having a first stroke and that the incidence rates are actually increasing in the younger age range (people under 55). In DIOMUNE we are working tirelessly to complete the development of our brain stroke treatment with... Read More
13
Oct
Diomune is one of 4 companies to sign the transparency agreement for the use of animal for scientific experimentation in Spain
Transparency agreement for the use of animals for scientific experimentation in Spain About 90 public and private institutions, among which is Diomune, just signed an agreement on transparency for the use of animals in scientific experimentation in Spain in order to open the doors of laboratories and show how they work and the guarantees and controls research work has... Read More
13
Oct
Diomune participates in BIOSPAIN, the largest biotechnology event organized by a national association of bioindustry in Europe
Spanish innovation is on the hunt for investors at BioSpain 2016 The event took place in Bilbao (Spain) from the 28th to 30th of September.
26
Oct
Autovaccine against Leishmaniasis
“Autovaccine against Leishmaniasis using a fluorescent parasite”
26
Oct
III Congreso Nacional de Científicos Emprendedores
DIOMUNE y Encuentros TEI Bio en Capital Radio
26
Oct
Innovation, Entrepreneurship and Society
DIOMUNE en laCajabierta